Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Rectal Neoplasms | 10 | 2022 | 62 | 4.710 |
Why?
|
Transanal Endoscopic Surgery | 6 | 2021 | 15 | 4.050 |
Why?
|
Digestive System Surgical Procedures | 13 | 2021 | 74 | 3.180 |
Why?
|
Rectum | 10 | 2022 | 61 | 3.170 |
Why?
|
Laparoscopy | 19 | 2021 | 295 | 3.000 |
Why?
|
Colonoscopy | 9 | 2022 | 94 | 2.640 |
Why?
|
Colectomy | 16 | 2019 | 71 | 2.490 |
Why?
|
Anastomotic Leak | 4 | 2021 | 19 | 2.040 |
Why?
|
Crohn Disease | 8 | 2021 | 84 | 1.830 |
Why?
|
Colon | 9 | 2021 | 128 | 1.780 |
Why?
|
Colonic Neoplasms | 8 | 2016 | 180 | 1.770 |
Why?
|
Colorectal Surgery | 7 | 2021 | 30 | 1.600 |
Why?
|
Postoperative Complications | 20 | 2021 | 900 | 1.540 |
Why?
|
Colonic Polyps | 2 | 2022 | 23 | 1.510 |
Why?
|
Adenocarcinoma | 5 | 2019 | 307 | 1.370 |
Why?
|
Colitis, Ulcerative | 4 | 2020 | 48 | 1.300 |
Why?
|
Perineum | 4 | 2021 | 16 | 1.270 |
Why?
|
Rectal Diseases | 5 | 2020 | 18 | 1.190 |
Why?
|
Anastomosis, Surgical | 4 | 2021 | 70 | 1.180 |
Why?
|
Diverticulitis | 3 | 2020 | 21 | 1.180 |
Why?
|
Surgeons | 3 | 2021 | 94 | 1.180 |
Why?
|
Middle Aged | 50 | 2022 | 13613 | 1.170 |
Why?
|
Treatment Outcome | 24 | 2021 | 3801 | 1.100 |
Why?
|
Proctocolectomy, Restorative | 2 | 2020 | 5 | 1.080 |
Why?
|
Colonic Pouches | 2 | 2020 | 7 | 1.080 |
Why?
|
Retrospective Studies | 37 | 2022 | 4304 | 1.060 |
Why?
|
Humans | 87 | 2022 | 48136 | 1.050 |
Why?
|
Colorectal Neoplasms | 6 | 2020 | 197 | 1.040 |
Why?
|
Elective Surgical Procedures | 9 | 2021 | 105 | 1.020 |
Why?
|
Pelvis | 2 | 2021 | 55 | 1.010 |
Why?
|
Diverticulitis, Colonic | 5 | 2020 | 18 | 1.000 |
Why?
|
Colonic Diseases | 7 | 2020 | 33 | 1.000 |
Why?
|
Digestive System Fistula | 1 | 2021 | 4 | 0.950 |
Why?
|
Tomography, X-Ray Computed | 6 | 2019 | 1055 | 0.940 |
Why?
|
Female | 60 | 2022 | 26270 | 0.930 |
Why?
|
Male | 60 | 2021 | 23358 | 0.920 |
Why?
|
Reoperation | 3 | 2021 | 187 | 0.910 |
Why?
|
Clostridium Infections | 1 | 2020 | 32 | 0.830 |
Why?
|
Academic Medical Centers | 3 | 2017 | 261 | 0.810 |
Why?
|
Delphi Technique | 1 | 2019 | 55 | 0.790 |
Why?
|
Embolism, Air | 1 | 2018 | 8 | 0.780 |
Why?
|
Length of Stay | 11 | 2021 | 615 | 0.780 |
Why?
|
Carbon Dioxide | 1 | 2018 | 63 | 0.750 |
Why?
|
Anus Diseases | 2 | 2015 | 3 | 0.700 |
Why?
|
Patient Readmission | 5 | 2020 | 347 | 0.690 |
Why?
|
Rectal Fistula | 2 | 2015 | 8 | 0.690 |
Why?
|
Abscess | 2 | 2015 | 63 | 0.660 |
Why?
|
Aged | 35 | 2021 | 10902 | 0.650 |
Why?
|
Adult | 35 | 2022 | 13290 | 0.640 |
Why?
|
Quality Improvement | 9 | 2019 | 319 | 0.620 |
Why?
|
Total Quality Management | 1 | 2015 | 52 | 0.610 |
Why?
|
Patient Safety | 1 | 2017 | 184 | 0.600 |
Why?
|
Chemoradiotherapy, Adjuvant | 1 | 2014 | 13 | 0.580 |
Why?
|
Efficiency, Organizational | 1 | 2015 | 87 | 0.580 |
Why?
|
Stromal Cells | 1 | 2014 | 59 | 0.550 |
Why?
|
Interleukin Receptor Common gamma Subunit | 1 | 2014 | 73 | 0.540 |
Why?
|
Neoplasm Staging | 7 | 2022 | 357 | 0.530 |
Why?
|
Colon, Sigmoid | 2 | 2013 | 7 | 0.510 |
Why?
|
Colostomy | 2 | 2011 | 8 | 0.510 |
Why?
|
Healthcare Disparities | 2 | 2016 | 244 | 0.510 |
Why?
|
Rectal Prolapse | 3 | 2019 | 10 | 0.500 |
Why?
|
Morbidity | 6 | 2021 | 83 | 0.490 |
Why?
|
Homeodomain Proteins | 1 | 2014 | 237 | 0.490 |
Why?
|
Enteral Nutrition | 2 | 2002 | 34 | 0.480 |
Why?
|
Risk Assessment | 7 | 2020 | 1590 | 0.470 |
Why?
|
Anal Canal | 3 | 2020 | 26 | 0.470 |
Why?
|
Internship and Residency | 6 | 2020 | 578 | 0.470 |
Why?
|
Health Status Disparities | 2 | 2013 | 127 | 0.450 |
Why?
|
Gastrointestinal Diseases | 1 | 2011 | 74 | 0.450 |
Why?
|
General Surgery | 3 | 2020 | 119 | 0.450 |
Why?
|
Hemorrhoids | 1 | 2010 | 4 | 0.420 |
Why?
|
Risk Factors | 19 | 2020 | 4217 | 0.420 |
Why?
|
Cutaneous Fistula | 2 | 2015 | 4 | 0.410 |
Why?
|
Patient Discharge | 4 | 2021 | 385 | 0.400 |
Why?
|
Minimally Invasive Surgical Procedures | 4 | 2016 | 61 | 0.380 |
Why?
|
Follow-Up Studies | 7 | 2021 | 1960 | 0.380 |
Why?
|
Operative Time | 2 | 2021 | 50 | 0.380 |
Why?
|
Intubation, Gastrointestinal | 2 | 2014 | 16 | 0.380 |
Why?
|
United States | 17 | 2021 | 6136 | 0.370 |
Why?
|
Surgical Wound Infection | 3 | 2014 | 74 | 0.370 |
Why?
|
Surgical Procedures, Operative | 3 | 2015 | 130 | 0.370 |
Why?
|
Recurrence | 3 | 2020 | 510 | 0.340 |
Why?
|
Aged, 80 and over | 13 | 2021 | 4240 | 0.330 |
Why?
|
Proctitis | 2 | 2020 | 5 | 0.330 |
Why?
|
Feasibility Studies | 2 | 2021 | 406 | 0.330 |
Why?
|
Analgesics, Opioid | 2 | 2021 | 340 | 0.330 |
Why?
|
Colitis | 1 | 2006 | 73 | 0.310 |
Why?
|
Education, Medical, Graduate | 3 | 2020 | 232 | 0.310 |
Why?
|
Intestinal Obstruction | 2 | 2018 | 36 | 0.310 |
Why?
|
Fecal Incontinence | 2 | 2015 | 11 | 0.300 |
Why?
|
Adolescent | 10 | 2022 | 5495 | 0.290 |
Why?
|
Margins of Excision | 2 | 2022 | 31 | 0.290 |
Why?
|
Urinary Incontinence | 2 | 2015 | 29 | 0.290 |
Why?
|
Preoperative Care | 3 | 2019 | 157 | 0.280 |
Why?
|
Enterocolitis, Pseudomembranous | 2 | 2014 | 30 | 0.280 |
Why?
|
Anus Neoplasms | 2 | 2014 | 19 | 0.270 |
Why?
|
Perioperative Period | 2 | 2021 | 16 | 0.270 |
Why?
|
Databases, Factual | 6 | 2016 | 719 | 0.270 |
Why?
|
Practice Patterns, Physicians' | 3 | 2021 | 691 | 0.260 |
Why?
|
Intestinal Fistula | 1 | 2003 | 4 | 0.260 |
Why?
|
Pain, Postoperative | 2 | 2021 | 103 | 0.260 |
Why?
|
Critical Care | 3 | 2016 | 310 | 0.260 |
Why?
|
Feces | 2 | 2020 | 90 | 0.250 |
Why?
|
Home Care Services | 2 | 2020 | 91 | 0.250 |
Why?
|
Hospital Mortality | 3 | 2017 | 713 | 0.250 |
Why?
|
Gastric Emptying | 1 | 2002 | 3 | 0.250 |
Why?
|
Survival Rate | 5 | 2015 | 659 | 0.240 |
Why?
|
Propranolol | 1 | 2002 | 22 | 0.240 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2014 | 130 | 0.240 |
Why?
|
Military Personnel | 2 | 2013 | 70 | 0.240 |
Why?
|
Health Services Accessibility | 3 | 2015 | 433 | 0.240 |
Why?
|
Medical Chaperones | 1 | 2021 | 4 | 0.230 |
Why?
|
Abdominal Pain | 1 | 2022 | 77 | 0.230 |
Why?
|
Burns | 1 | 2002 | 58 | 0.230 |
Why?
|
Aftercare | 1 | 2021 | 50 | 0.230 |
Why?
|
Ileostomy | 1 | 2021 | 8 | 0.230 |
Why?
|
Oxycodone | 1 | 2021 | 33 | 0.230 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2002 | 126 | 0.230 |
Why?
|
Constriction, Pathologic | 1 | 2021 | 57 | 0.220 |
Why?
|
Drainage | 3 | 2013 | 106 | 0.220 |
Why?
|
Abdomen | 3 | 2016 | 92 | 0.220 |
Why?
|
Fecal Microbiota Transplantation | 1 | 2020 | 6 | 0.220 |
Why?
|
Treatment Failure | 1 | 2021 | 170 | 0.220 |
Why?
|
Energy Intake | 1 | 2002 | 240 | 0.210 |
Why?
|
Prognosis | 5 | 2014 | 1260 | 0.210 |
Why?
|
Safety | 1 | 2021 | 131 | 0.210 |
Why?
|
Granuloma, Plasma Cell | 1 | 2020 | 2 | 0.210 |
Why?
|
Herpesvirus 2, Human | 1 | 2020 | 19 | 0.210 |
Why?
|
Laparotomy | 2 | 2015 | 33 | 0.210 |
Why?
|
Inappropriate Prescribing | 1 | 2021 | 48 | 0.210 |
Why?
|
Precancerous Conditions | 2 | 2013 | 59 | 0.210 |
Why?
|
Online Systems | 1 | 2020 | 21 | 0.210 |
Why?
|
Terminology as Topic | 1 | 2021 | 123 | 0.210 |
Why?
|
Herpes Simplex | 1 | 2020 | 34 | 0.210 |
Why?
|
Herpesvirus 1, Human | 1 | 2020 | 52 | 0.200 |
Why?
|
Drug Prescriptions | 1 | 2021 | 177 | 0.200 |
Why?
|
Skilled Nursing Facilities | 1 | 2020 | 76 | 0.200 |
Why?
|
Intestinal Diseases | 2 | 2014 | 45 | 0.200 |
Why?
|
Energy Metabolism | 1 | 2002 | 333 | 0.200 |
Why?
|
Unnecessary Procedures | 2 | 2016 | 31 | 0.200 |
Why?
|
Drug Utilization | 1 | 2021 | 221 | 0.200 |
Why?
|
Insurance Coverage | 2 | 2016 | 88 | 0.200 |
Why?
|
Time Factors | 7 | 2019 | 3230 | 0.190 |
Why?
|
Young Adult | 10 | 2016 | 3668 | 0.190 |
Why?
|
Endothelium, Vascular | 1 | 2020 | 158 | 0.190 |
Why?
|
Social Media | 1 | 2020 | 102 | 0.190 |
Why?
|
Early Detection of Cancer | 3 | 2015 | 170 | 0.180 |
Why?
|
Intestine, Small | 1 | 2018 | 96 | 0.180 |
Why?
|
Colon, Transverse | 1 | 2017 | 4 | 0.170 |
Why?
|
Hospital Costs | 2 | 2014 | 94 | 0.170 |
Why?
|
Pregnancy Complications | 2 | 2014 | 381 | 0.170 |
Why?
|
Multivariate Analysis | 4 | 2021 | 878 | 0.170 |
Why?
|
Adenoma | 2 | 2013 | 52 | 0.160 |
Why?
|
Robotic Surgical Procedures | 1 | 2017 | 37 | 0.160 |
Why?
|
Logistic Models | 5 | 2014 | 1213 | 0.160 |
Why?
|
Surveys and Questionnaires | 2 | 2021 | 2304 | 0.160 |
Why?
|
Diagnosis, Differential | 3 | 2018 | 771 | 0.150 |
Why?
|
Inflammatory Bowel Diseases | 2 | 2020 | 63 | 0.150 |
Why?
|
Cholangiography | 1 | 2015 | 34 | 0.150 |
Why?
|
Severity of Illness Index | 5 | 2016 | 1185 | 0.150 |
Why?
|
Cholecystectomy | 1 | 2015 | 34 | 0.150 |
Why?
|
Hernia | 1 | 2015 | 10 | 0.150 |
Why?
|
Bibliometrics | 1 | 2015 | 23 | 0.150 |
Why?
|
Parenteral Nutrition | 2 | 2006 | 22 | 0.150 |
Why?
|
Specimen Handling | 1 | 2015 | 41 | 0.150 |
Why?
|
Odds Ratio | 2 | 2020 | 786 | 0.140 |
Why?
|
Fat Emulsions, Intravenous | 2 | 2006 | 34 | 0.140 |
Why?
|
Recovery of Function | 2 | 2013 | 192 | 0.140 |
Why?
|
Herniorrhaphy | 1 | 2015 | 49 | 0.140 |
Why?
|
Specific Pathogen-Free Organisms | 1 | 2014 | 45 | 0.140 |
Why?
|
Venous Thrombosis | 1 | 2015 | 100 | 0.140 |
Why?
|
Hemorrhoidectomy | 1 | 2014 | 1 | 0.140 |
Why?
|
Megacolon | 1 | 2014 | 1 | 0.140 |
Why?
|
Neoadjuvant Therapy | 1 | 2014 | 52 | 0.140 |
Why?
|
Incidence | 4 | 2014 | 1121 | 0.140 |
Why?
|
Fluorouracil | 1 | 2014 | 37 | 0.140 |
Why?
|
Lacerations | 1 | 2014 | 10 | 0.140 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2014 | 27 | 0.140 |
Why?
|
Program Development | 1 | 2015 | 210 | 0.140 |
Why?
|
Vancomycin | 1 | 2014 | 23 | 0.140 |
Why?
|
Obstetric Labor Complications | 1 | 2014 | 20 | 0.140 |
Why?
|
Pilonidal Sinus | 1 | 2013 | 2 | 0.140 |
Why?
|
Decompression, Surgical | 1 | 2014 | 24 | 0.140 |
Why?
|
Fibrin Tissue Adhesive | 1 | 2013 | 2 | 0.140 |
Why?
|
Tissue Adhesives | 1 | 2013 | 7 | 0.140 |
Why?
|
Antibiotic Prophylaxis | 1 | 2014 | 44 | 0.140 |
Why?
|
Liver Failure | 1 | 2013 | 15 | 0.140 |
Why?
|
Publishing | 1 | 2015 | 77 | 0.140 |
Why?
|
Intensive Care Units | 4 | 2020 | 322 | 0.130 |
Why?
|
Tertiary Healthcare | 1 | 2013 | 9 | 0.130 |
Why?
|
Population Surveillance | 1 | 2015 | 221 | 0.130 |
Why?
|
Appendicitis | 1 | 2014 | 60 | 0.130 |
Why?
|
Emergency Treatment | 1 | 2013 | 43 | 0.130 |
Why?
|
Cesarean Section | 1 | 2014 | 77 | 0.130 |
Why?
|
Defecation | 1 | 2012 | 7 | 0.130 |
Why?
|
Hospitals, Community | 1 | 2013 | 59 | 0.130 |
Why?
|
Autonomic Nervous System | 1 | 2012 | 29 | 0.130 |
Why?
|
Reflex | 1 | 2012 | 25 | 0.130 |
Why?
|
Mice, SCID | 1 | 2014 | 493 | 0.130 |
Why?
|
Mice, Inbred NOD | 1 | 2014 | 484 | 0.130 |
Why?
|
Sepsis | 1 | 2015 | 205 | 0.120 |
Why?
|
Urinary Bladder | 1 | 2012 | 36 | 0.120 |
Why?
|
HIV Infections | 1 | 2020 | 920 | 0.120 |
Why?
|
Predictive Value of Tests | 4 | 2020 | 855 | 0.120 |
Why?
|
Surgical Flaps | 1 | 2013 | 93 | 0.120 |
Why?
|
Fibroblasts | 1 | 2014 | 326 | 0.120 |
Why?
|
Minority Groups | 1 | 2013 | 109 | 0.120 |
Why?
|
Patient Satisfaction | 1 | 2015 | 372 | 0.120 |
Why?
|
Mentors | 1 | 2013 | 102 | 0.120 |
Why?
|
Observation | 1 | 2011 | 25 | 0.120 |
Why?
|
Periodicals as Topic | 1 | 2015 | 163 | 0.120 |
Why?
|
Medical Records | 1 | 2012 | 141 | 0.120 |
Why?
|
Biomedical Research | 1 | 2015 | 228 | 0.120 |
Why?
|
Ultrasonography | 1 | 2013 | 375 | 0.120 |
Why?
|
Patient Care Team | 1 | 2014 | 277 | 0.110 |
Why?
|
Intestinal Mucosa | 1 | 2013 | 222 | 0.110 |
Why?
|
Reconstructive Surgical Procedures | 1 | 2012 | 98 | 0.110 |
Why?
|
Guideline Adherence | 1 | 2013 | 271 | 0.110 |
Why?
|
Practice Guidelines as Topic | 3 | 2021 | 605 | 0.110 |
Why?
|
Pregnancy | 3 | 2014 | 1947 | 0.110 |
Why?
|
Ligation | 1 | 2010 | 28 | 0.110 |
Why?
|
Acute Kidney Injury | 1 | 2011 | 96 | 0.100 |
Why?
|
Muscle, Skeletal | 2 | 2006 | 579 | 0.100 |
Why?
|
Postoperative Period | 2 | 2013 | 106 | 0.100 |
Why?
|
Acute Disease | 3 | 2016 | 624 | 0.100 |
Why?
|
Data Accuracy | 2 | 2020 | 25 | 0.090 |
Why?
|
Anti-Bacterial Agents | 1 | 2014 | 567 | 0.090 |
Why?
|
Animals | 5 | 2014 | 17802 | 0.090 |
Why?
|
Insulin | 2 | 2002 | 674 | 0.090 |
Why?
|
Life Style | 1 | 2010 | 316 | 0.090 |
Why?
|
Emergencies | 2 | 2010 | 87 | 0.090 |
Why?
|
Comorbidity | 3 | 2017 | 996 | 0.090 |
Why?
|
Disease Models, Animal | 1 | 2014 | 1788 | 0.090 |
Why?
|
Cohort Studies | 3 | 2019 | 2072 | 0.080 |
Why?
|
Quality of Life | 1 | 2012 | 716 | 0.080 |
Why?
|
Cross-Sectional Studies | 3 | 2021 | 2036 | 0.080 |
Why?
|
Magnetic Resonance Imaging | 1 | 2013 | 1345 | 0.080 |
Why?
|
Propensity Score | 2 | 2015 | 112 | 0.070 |
Why?
|
Fatty Acids | 1 | 2006 | 170 | 0.070 |
Why?
|
Myocardial Infarction | 1 | 2011 | 863 | 0.070 |
Why?
|
Lipid Metabolism | 1 | 2006 | 197 | 0.070 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2004 | 53 | 0.070 |
Why?
|
Washington | 2 | 2013 | 37 | 0.070 |
Why?
|
Peptide Hormones | 1 | 2002 | 6 | 0.060 |
Why?
|
Obesity | 1 | 2011 | 1161 | 0.060 |
Why?
|
Workload | 2 | 2014 | 101 | 0.060 |
Why?
|
Pylorus | 1 | 2002 | 7 | 0.060 |
Why?
|
Intestines | 1 | 2004 | 155 | 0.060 |
Why?
|
Blood Glucose | 2 | 2002 | 448 | 0.060 |
Why?
|
Jejunum | 1 | 2002 | 22 | 0.060 |
Why?
|
Skin Diseases | 1 | 2003 | 65 | 0.060 |
Why?
|
Glycogen | 1 | 2002 | 40 | 0.060 |
Why?
|
Nutritional Status | 1 | 2003 | 116 | 0.060 |
Why?
|
Postoperative Care | 1 | 2002 | 90 | 0.060 |
Why?
|
Dietary Carbohydrates | 1 | 2002 | 80 | 0.060 |
Why?
|
Organizational Policy | 1 | 2021 | 55 | 0.060 |
Why?
|
Renal Dialysis | 1 | 2003 | 171 | 0.060 |
Why?
|
Muscle Proteins | 1 | 2002 | 104 | 0.060 |
Why?
|
Liver | 1 | 2006 | 714 | 0.060 |
Why?
|
Program Evaluation | 2 | 2014 | 453 | 0.060 |
Why?
|
Evidence-Based Medicine | 2 | 2015 | 365 | 0.060 |
Why?
|
Mice | 1 | 2014 | 8952 | 0.060 |
Why?
|
Outpatients | 1 | 2021 | 101 | 0.050 |
Why?
|
Accreditation | 1 | 2020 | 54 | 0.050 |
Why?
|
Prevalence | 2 | 2014 | 1122 | 0.050 |
Why?
|
Specialty Boards | 1 | 2020 | 13 | 0.050 |
Why?
|
Hypoglycemic Agents | 1 | 2002 | 191 | 0.050 |
Why?
|
Computer Terminals | 1 | 1999 | 5 | 0.050 |
Why?
|
Positron Emission Tomography Computed Tomography | 1 | 2020 | 33 | 0.050 |
Why?
|
Laparoscopes | 1 | 1999 | 20 | 0.050 |
Why?
|
Glucose | 1 | 2002 | 384 | 0.050 |
Why?
|
Age Factors | 2 | 2014 | 1446 | 0.050 |
Why?
|
Long-Term Care | 1 | 2020 | 168 | 0.050 |
Why?
|
Critical Illness | 1 | 2002 | 251 | 0.050 |
Why?
|
Superior Mesenteric Artery Syndrome | 1 | 2018 | 1 | 0.050 |
Why?
|
Appointments and Schedules | 1 | 2019 | 41 | 0.050 |
Why?
|
Child | 2 | 2020 | 3773 | 0.050 |
Why?
|
Pancreatic Diseases | 1 | 2018 | 29 | 0.050 |
Why?
|
Endothelial Cells | 1 | 2020 | 146 | 0.050 |
Why?
|
Lymph Nodes | 1 | 2019 | 213 | 0.050 |
Why?
|
Tissue Adhesions | 1 | 2018 | 28 | 0.050 |
Why?
|
Rats, Sprague-Dawley | 3 | 2006 | 503 | 0.050 |
Why?
|
Self Report | 1 | 2021 | 300 | 0.050 |
Why?
|
Universities | 1 | 2019 | 126 | 0.050 |
Why?
|
Needs Assessment | 1 | 2019 | 158 | 0.050 |
Why?
|
Pancreas | 1 | 2018 | 134 | 0.040 |
Why?
|
Stomach Neoplasms | 1 | 2018 | 75 | 0.040 |
Why?
|
Antiviral Agents | 1 | 2020 | 242 | 0.040 |
Why?
|
Diffusion of Innovation | 1 | 2017 | 58 | 0.040 |
Why?
|
Infant, Newborn | 1 | 2020 | 1042 | 0.040 |
Why?
|
Image Processing, Computer-Assisted | 1 | 1999 | 533 | 0.040 |
Why?
|
Rats | 3 | 2006 | 1795 | 0.040 |
Why?
|
Hospitals, High-Volume | 1 | 2016 | 19 | 0.040 |
Why?
|
Occult Blood | 1 | 2015 | 11 | 0.040 |
Why?
|
Colonography, Computed Tomographic | 1 | 2015 | 20 | 0.040 |
Why?
|
Infant | 1 | 2020 | 1361 | 0.040 |
Why?
|
Symptom Assessment | 1 | 2015 | 35 | 0.040 |
Why?
|
Tertiary Care Centers | 1 | 2016 | 80 | 0.040 |
Why?
|
Fissure in Ano | 1 | 2015 | 2 | 0.040 |
Why?
|
Internet | 1 | 2020 | 465 | 0.040 |
Why?
|
Bile | 1 | 2015 | 15 | 0.040 |
Why?
|
Hospital Charges | 1 | 2015 | 21 | 0.040 |
Why?
|
Hawaii | 1 | 2015 | 17 | 0.040 |
Why?
|
Medical Illustration | 1 | 2015 | 7 | 0.040 |
Why?
|
Intraoperative Care | 1 | 2015 | 40 | 0.040 |
Why?
|
Child, Preschool | 1 | 2020 | 1775 | 0.040 |
Why?
|
Surgical Mesh | 1 | 2015 | 48 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2015 | 74 | 0.040 |
Why?
|
Phospholipids | 2 | 2006 | 72 | 0.040 |
Why?
|
Episiotomy | 1 | 2014 | 1 | 0.040 |
Why?
|
Obstetrical Forceps | 1 | 2014 | 2 | 0.040 |
Why?
|
Vacuum Extraction, Obstetrical | 1 | 2014 | 4 | 0.030 |
Why?
|
Enema | 1 | 2014 | 9 | 0.030 |
Why?
|
Administration, Topical | 1 | 2014 | 39 | 0.030 |
Why?
|
Combined Modality Therapy | 1 | 2015 | 309 | 0.030 |
Why?
|
Cost of Illness | 1 | 2014 | 137 | 0.030 |
Why?
|
Costs and Cost Analysis | 1 | 2014 | 91 | 0.030 |
Why?
|
United States Department of Defense | 1 | 2013 | 1 | 0.030 |
Why?
|
Intestinal Polyps | 1 | 2013 | 7 | 0.030 |
Why?
|
Wounds, Penetrating | 1 | 2013 | 16 | 0.030 |
Why?
|
Injury Severity Score | 1 | 2013 | 70 | 0.030 |
Why?
|
Ileum | 1 | 2013 | 22 | 0.030 |
Why?
|
Cost-Benefit Analysis | 1 | 2014 | 235 | 0.030 |
Why?
|
Quality Indicators, Health Care | 1 | 2016 | 317 | 0.030 |
Why?
|
Wounds, Nonpenetrating | 1 | 2013 | 49 | 0.030 |
Why?
|
ROC Curve | 1 | 2013 | 235 | 0.030 |
Why?
|
Disease-Free Survival | 1 | 2013 | 195 | 0.030 |
Why?
|
Gastroenterology | 1 | 2013 | 35 | 0.030 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2014 | 228 | 0.030 |
Why?
|
Clinical Competence | 2 | 2012 | 526 | 0.030 |
Why?
|
Liver Diseases | 1 | 2013 | 112 | 0.030 |
Why?
|
Patient Selection | 1 | 2015 | 361 | 0.030 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2012 | 54 | 0.030 |
Why?
|
Sex Factors | 1 | 2015 | 859 | 0.030 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2012 | 77 | 0.030 |
Why?
|
Clinical Trials as Topic | 1 | 2015 | 376 | 0.030 |
Why?
|
Societies, Medical | 1 | 2013 | 217 | 0.030 |
Why?
|
Teaching | 1 | 2013 | 161 | 0.030 |
Why?
|
Proportional Hazards Models | 1 | 2013 | 640 | 0.030 |
Why?
|
Inpatients | 1 | 2014 | 246 | 0.030 |
Why?
|
Research Design | 1 | 2015 | 528 | 0.030 |
Why?
|
Socioeconomic Factors | 1 | 2014 | 790 | 0.030 |
Why?
|
Mass Screening | 1 | 2015 | 528 | 0.030 |
Why?
|
Registries | 1 | 2014 | 673 | 0.030 |
Why?
|
Massachusetts | 1 | 2016 | 2033 | 0.030 |
Why?
|
Reproducibility of Results | 1 | 2015 | 1339 | 0.030 |
Why?
|
Chi-Square Distribution | 1 | 2010 | 408 | 0.030 |
Why?
|
Hospitalization | 1 | 2016 | 1056 | 0.020 |
Why?
|
Decision Making | 1 | 2012 | 319 | 0.020 |
Why?
|
Diagnostic Imaging | 1 | 2011 | 201 | 0.020 |
Why?
|
Weight Loss | 1 | 2010 | 258 | 0.020 |
Why?
|
Body Mass Index | 1 | 2011 | 920 | 0.020 |
Why?
|
Short Bowel Syndrome | 1 | 2006 | 2 | 0.020 |
Why?
|
Fatty Acids, Omega-6 | 1 | 2006 | 9 | 0.020 |
Why?
|
Algorithms | 1 | 2011 | 881 | 0.020 |
Why?
|
Prospective Studies | 1 | 2012 | 2479 | 0.020 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2006 | 41 | 0.020 |
Why?
|
Random Allocation | 1 | 2006 | 200 | 0.020 |
Why?
|
Smoking | 1 | 2010 | 778 | 0.020 |
Why?
|
Soybean Oil | 1 | 2004 | 32 | 0.020 |
Why?
|
Animal Feed | 1 | 2002 | 14 | 0.020 |
Why?
|
Ghrelin | 1 | 2002 | 10 | 0.020 |
Why?
|
Nutritional Support | 1 | 2002 | 6 | 0.020 |
Why?
|
Infusions, Intravenous | 1 | 2002 | 165 | 0.020 |
Why?
|
Cardiac Surgical Procedures | 1 | 2002 | 120 | 0.010 |
Why?
|
Models, Educational | 1 | 1999 | 60 | 0.010 |
Why?
|
Task Performance and Analysis | 1 | 1999 | 99 | 0.010 |
Why?
|